Netherlands· NL-01dcaa01a3f0
Ventavis 10 microgram/ml, verneveloplossing
A iloprost product containing iloprost, registered in Netherlands by Bayer AG. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Iloprost is registered in 12 of 19 countries.
Countries holding a registration under ATC B01AC11 (iloprost), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Iloprost · ATC B01AC11
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of iloprost costs, country by country.
Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Iloprost · price per daily dose (0.15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$252.43
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ILOPROST
- Manufacturer
- Bayer AG
- Country
- Netherlands (NL)
- ATC code
- B01AC11
- ATC class
- Iloprost
- Defined daily dose
- 0.15 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/03/255
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
408 interactions on record for iloprost.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iloprost · interactions on record
408 records
- 34 severe
- 274 moderate
- 2 minor
- 96 info
Most severe, free to view
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
- TinzaparinB01AB10severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iloprost in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainILOPROST RAFARM 10 MICROGRAMOS/ML SOLUCION PARA INHALACION POR NEBULIZADORRafarm S.A.
- BelgiumVentavis 10 µg/mlBayer
- FinlandIloprost ZentivaZentiva, k.s.
- PolandIloprost ZentivaZentiva, k.s.
- SwedenIloprost Zentiva 10 mikrogram/ml Lösning för nebulisatorZentiva k.s.
- SwitzerlandVentavis, Lösung für einen VerneblerBayer (Schweiz) AG
- NorwayVentavisBayer AG
- IrelandVentavis 10 microgram/ml nebuliser solutionBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Ilomedin, Iloprost
- Bulgaria · Иломедин
- Czechia · Calovat, Iloprost Zentiva
- Germany · Ilomedin, Iloprost Rafarm
- Denmark · Ilomedin, Iloprost
- Spain · Ilomedin, Iloprost Rafarm
- Finland · Ilomedin
- France · Ilomedine, Iloprost Teva
- United Kingdom (Northern Ireland) · Iloprost Colonis Pharma, Iloprost Galvany Pharma
- Greece · Ilomedin, Iloprost Rafarm
- Hungary · Ilomedin
- Ireland · Iloprost Waymade
- Iceland · Ventavis
- Italy · Endoprost, Iloprost Rafarm
- Liechtenstein · Ventavis
- Malta · Iloprost Pharmamentum
- Norway · Ilomedin, Ventavis
- Portugal · Ilomedin, Iloprost
- Romania · Ilomedin 20
- Sweden · Ilomedin, Iloprost
- Slovenia · Ilomedin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4cfd7b1-6b52-4af9-ae96-752db1243311 GET /v1/drugs/e4cfd7b1-6b52-4af9-ae96-752db1243311?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Verneveloplossing",
"route": "Inhalatie",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ventavis-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Iloprost",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71639",
"excipients": [
"ETHANOL 96 %",
"NATRIUMCHLORIDE",
"TROMETAMOL",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"ILOPROST"
],
"leaflet_url": null,
"authorised_at": "2003/09/16",
"procedure_number": "EMEA/H/C/000474",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/03/255",
"additional_monitoring": "N"
}See everything about iloprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.